First trimester thyroid function in pregnant women residing in Saint Petersburg (Russia): reference values and risk of gestational diabetes

Background. Subclinical hypothyroidism during pregnancy and gestational diabetes mellitus (GDM) is known to be associated with maternal and child morbidity. The concept of subclinical dysfunction of the thyroid gland in pregnant women depends on the population-specific and trimester-specific reference values so fixed universal cutoff concentrations for thyroid-stimulating hormone (TSH) that were recommended earlier now are put under the question. Population-specific and trimester-specific reference values have not been defined for pregnant women residing in Saint Petersburg. The data concerning the association of maternal thyroid status with GDM development are controversial.

Aims. The aim of the study was to determine the reference values of TSH and free thyroxin (fT4) in the first trimester of pregnancy in women living in St. Petersburg, and to assess the relationship between thyroid status and the risk of subsequent development of GDM.

Materials and methods. The levels of TSH, fT4 and thyroid peroxidase antibodies (TPO-Ab) were analyzed in 503 pregnant women before the 14th week of gestation. The women underwent oral glucose tolerance test (OGTT) at 24–28 weeks to find out those with GDM. The association between thyroid function, thyroid autoimmunity and the risk of GDM we estimated.

Results. The reference values for TSH were 0.07 – 4.40 mU /L, and for fT4 11.7 – 20.3 pmol/L. The prevalence of subclinical hypothyroidism in the 503 pregnant women was 16.9% according to the diagnostic criteria of TSH> 2.5 mIU / L and 3.8% using our calculated reference interval. Hypothyroxinemia was registered in 5,3% using reference values recommended by diagnostic tests manufacturer and in 2,8% according to our calculated reference interval for fT4. GDM was diagnosed in 23% of women. Logistic regression analysis showed associations of hypothyroxinemia and TPO-Ab-positivity with the increased risk of GDM that remained significant after adjustments on age and body mass index (BMI) [adjusted OR (95% CI) = 7.39 (1.27–42.93) for hypothyroxinemia, p=0.026; and adjusted OR (95% CI) = 2.02 (1.01–4.04) for TPO-Ab-positivity, p=0.047).

Conclusions. Reference intervals for first trimester TSH and fT4 have been established for pregnant women living in St. Petersburg. Hypothyroxinemia and TPO-Ab-positivity were associated with the increased risk of GDM.

gestational diabetes mellitus, thyrotropin, thyroxine, reference values

1. Lazarus J, Brown RS, Daumerie C, et al. 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014;3(2):76-94. doi: 10.1159/000362597

2. Фадеев В.В. По материалам клинических рекомендаций по диагностике и лечению заболеваний щитовидной железы во время беременности и в послеродовом периоде Американской тиреоидной ассоциации // Клиническая и экспериментальная тиреоидология. — 2012. — Т. 8. — №1. — С. 7-18. [Fadeyev VV. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum. Clinical and experimental thyroidology. 2012;8(1):7-18. (In Russ.)] doi: 10.14341/ket2012817-18

3. Maraka S, Ospina NM, O'Keeffe DT, et al. Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis. Thyroid. 2016;26(4):580-590. doi: 10.1089/thy.2015.0418

4. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315-389. doi: 10.1089/thy.2016.0457

5. Blatt AJ, Nakamoto JM, Kaufman HW. National status of testing for hypothyroidism during pregnancy and postpartum. J Clin Endocrinol Metab. 2012;97(3):777-784. doi: 10.1210/jc.2011-2038

6. Li C, Shan Z, Mao J, et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women? J Clin Endocrinol Metab. 2014;99(1):73-79. doi: 10.1210/jc.2013-1674

7. Guariguata L, Linnenkamp U, Beagley J, et al. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract. 2014;103(2):176-185. doi: 10.1016/j.diabres.2013.11.003

8. Group HSCR, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991-2002. doi: 10.1056/NEJMoa0707943

9. Tudela CM, Casey BM, McIntire DD, Cunningham FG. Relationship of subclinical thyroid disease to the incidence of gestational diabetes. Obstet Gynecol. 2012;119(5):983-988. doi: 10.1097/AOG.0b013e318250aeeb

10. Gorar S, Abanonu GB, Uysal A, et al. Comparison of thyroid function tests and blood count in pregnant women with versus without gestational diabetes mellitus. J Obstet Gynaecol Res. 2017;43(5):848-854. doi: 10.1111/jog.13280

11. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol. 2008;112(1):85-92. doi: 10.1097/AOG.0b013e3181788dd7

12. Эндокринология: национальное руководство. / Под ред. Дедова И.И., Мельниченко Г.А. — М.: ГЭОТАР-Медиа; 2008. [Dedov II, Mel’nichenko GA, editors. Endokrinologiya: natsional'noe rukovodstvo. Moscow: GEOTAR-Media; 2008. (In Russ.)]

13. Дедов И.И., Краснопольский В.И., Сухих Г.Т. Российский национальный консенсус «Гестационный сахарный диабет: диагностика, лечение, послеродовое наблюдение» // Сахарный диабет. — 2012. — Т. 15. — №4. — С. 4-10. [Dedov II, Krasnopol’skiy VI, Sukhikh GT. Russian National Consensus Statement on gestational diabetes: diagnostics, treatment and postnatal care. Diabetes Mellitus. 2012;15(4):4-10. (In Russ.)] doi: 10.14341/2072-0351-5531

14. Gilbert RM, Hadlow NC, Walsh JP, et al. Assessment of thyroid function during pregnancy: first-trimester (weeks 9-13) reference intervals derived from Western Australian women. Med J Aust. 2008;189(5):250-253.

15. Соболева Д.Е., Дора С.В., Волкова А.Р., и др. Йодообеспечение беременных женщин Санкт-Петербурга. Эффективность профилактики развития йододефицитных заболеваний в группе риска // Проблемы женского здоровья. — 2015. — Т. 10. — №2. — С. 25-31. [Soboleva DE, Dora SV, Volkova AR, et al. Iodine status of pregnant women living in Saint Petersburg. The effectiveness of iodine prevention in risk group. Problemy zhenskogo zdorov'ya. 2015;10(2):25-31. (In Russ.)]

16. Avalos GE, Owens LA, Dunne F, Collaborators AD. Applying current screening tools for gestational diabetes mellitus to a European population: is it time for change? Diabetes Care. 2013;36(10):3040-3044. doi: 10.2337/dc12-2669

17. Yang Y, Li Q, Wang Q, Ma X. Thyroid antibodies and gestational diabetes mellitus: a meta-analysis. Fertil Steril. 2015;104(3):665-671 e663. doi: 10.1016/j.fertnstert.2015.06.003

18. Yang S, Shi FT, Leung PC, et al. Low Thyroid Hormone in Early Pregnancy Is Associated With an Increased Risk of Gestational Diabetes Mellitus. J Clin Endocrinol Metab. 2016;101(11):4237-4243. doi: 10.1210/jc.2016-1506

19. Oguz A, Tuzun D, Sahin M, et al. Frequency of isolated maternal hypothyroxinemia in women with gestational diabetes mellitus in a moderately iodine-deficient area. Gynecol Endocrinol. 2015;31(10):792-795. doi: 10.3109/09513590.2015.1054801

20. Ying H, Tang YP, Bao YR, et al. Maternal TSH level and TPOAb status in early pregnancy and their relationship to the risk of gestational diabetes mellitus. Endocrine. 2016;54(3):742-750. doi: 10.1007/s12020-016-1022-6